Jane Street
STAB

Jane Street’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Jane Street’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35,422
Closed -$10K – 10809
2022
Q2 		$10K Buy
35,422
+24,661
+229% +$6.38K ﹤0.01% 9321
2022
Q1 		$3K Buy
+10,761
New +$11.5K ﹤0.01% 10158

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial Services Advisors
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Jane Street's STAB Position: Q3 2022 in Review

Jane Street sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2022, closing a stake of 35,422 shares — an estimated $10K sold.

Jane Street first reported a position in STAB in Q1 2022 and held it in 2 quarters. The position peaked at $10K in Q2 2022. 35 funds tracked by Wall St. Rank hold STAB as of Q3 2022.

  • Jane Street reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Jane Street sold 35,422 Statera Biopharma, Inc. Common Stock shares in Q3 2022, an estimated $10K.
  • Jane Street first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Jane Street's Statera Biopharma, Inc. Common Stock position peaked at $10K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.